Advertisement
Advertisement
U.S. markets open in 7 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Resonance Health Limited (RHT.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.1150+0.0050 (+4.55%)
At close: 11:03AM AEDT
Advertisement

Resonance Health Limited

141 Burswood Road
Ground Floor, Suite 2
Burswood, WA 6100
Australia
61 8 9286 5300
http://www.resonancehealth.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Mitchell M. Wells B.Com., L.L.B., LLB, B.CommMD & Exec. Director130kN/A1975
Mr. Nicholas Allan A.C.A., B.Com.CFO & Company Sec.N/AN/AN/A
Chat TondutCommunications Mang.N/AN/AN/A
Mr. Ajay NairGen. Mang. of Global Sales & MarketingN/AN/AN/A
Ms. Celine RoyetQuality Assurance & Regulatory Affairs Mang.N/AN/AN/A
Dr. Jason Loveridge B.Sc, B.Sc., FRSM, Ph.D.Corp. AdvisorN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services in the Asia Pacific, North America, Europe, the Middle East, and Africa. Its principal product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration (LIC). The company also provides FerriSmart, an artificial intelligence (AI) driven system for the automated real-time measurement of LIC; HepaFat-AI, an AI driven system for the automated real-time multi-metric measurement of liver fat; Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a non-invasive MRI-based solution for the measurement of volume fraction of fat in liver tissue; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. In addition, it offers imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Corporate Governance

Resonance Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement